Although this is a retrospective study with a small sample size of HER2-enriched type breast cancer and TNBC patients, to the best of our knowledge, it is the only study on elderly patients aged over 70 years with clinically negative axillary lymph nodes which compared BCSNR and MALND. Here, ERBB2 is linked to breast carcinoma.